Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Natco Pharma Limited
NATCOPHARMNATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. Address: Natco House, Hyderabad, India, 500034
Analytics
Preço Alvo de Wall Street
113 397.63 INRRácio P/E
12.6742Rendimento de dividendos
0.4 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave NATCOPHARM
Análise de Dividendos NATCOPHARM
Crescimento de dividendos em 5 anos
12 %Crescimento contínuo
2 anosTaxa de pagamento em média de 5 anos
32 %Histórico de Dividendos NATCOPHARM
Avaliação de ações NATCOPHARM
Relatório NATCOPHARM
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |